Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04447703
What this trial is testing

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaStage IIIB Prostate Cancer AJCC v8+2 more
Thomas Jefferson University 346
Early research (Phase 1)Ended earlyNCT04279561
What this trial is testing

Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8+2 more
Jonsson Comprehensive Cancer Center 9
Very early researchLooking for participantsNCT05045066
What this trial is testing

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

Who this might be right for
Localized Prostate CarcinomaStage IV Prostate Cancer AJCC v8Locally Recurrent Prostate Carcinoma+1 more
Mayo Clinic 220
Very early researchStudy completedNCT04976257
What this trial is testing

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaStage IIC Prostate Cancer AJCC v8+7 more
Ryan Kohlbrenner, MD 5
Not applicableLooking for participantsNCT05627219
What this trial is testing

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Who this might be right for
Metastatic Prostate CarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8+1 more
Thomas Jefferson University 30
Very early researchStudy completedNCT04067960
What this trial is testing

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+45 more
Mayo Clinic 197
Testing effectiveness (Phase 2)Looking for participantsNCT06173362
What this trial is testing

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Who this might be right for
Advanced Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8
University of California, Davis 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04471974
What this trial is testing

ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaMetastatic Prostate Small Cell Carcinoma+3 more
Rahul Aggarwal 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05960578
What this trial is testing

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaProstate AdenocarcinomaStage IV Prostate Cancer AJCC v8
University of Washington 8
Testing effectiveness (Phase 2)Looking for participantsNCT05054296
What this trial is testing

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT04716725
What this trial is testing

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
Thomas Hope 15
Large-scale testing (Phase 3)Looking for participantsNCT03678025
What this trial is testing

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
SWOG Cancer Research Network 1,273
Testing effectiveness (Phase 2)Study completedNCT04050215
What this trial is testing

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
Jonsson Comprehensive Cancer Center 937
Very early researchStudy completedNCT03987217
What this trial is testing

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

Who this might be right for
FatigueMetastatic Prostate CarcinomaSedentary Lifestyle+3 more
University of Utah 73
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)WithdrawnNCT03709550
What this trial is testing

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma in the Soft Tissue+6 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Early research (Phase 1)Study completedNCT03784677
What this trial is testing

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
M.D. Anderson Cancer Center 11
Next Page